UK markets closed

Atea Pharmaceuticals, Inc. (AVIR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.9200+0.0200 (+0.51%)
At close: 04:00PM EDT
3.9200 0.00 (0.00%)
After hours: 04:02PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
351,367
48,633
-
Operating expenses
Research development
142,864
114,243
81,936
167,205
38,023
-
Selling general and administrative
49,535
49,919
48,714
45,785
21,640
-
Total operating expenses
192,399
164,162
130,650
212,990
59,663
-
Operating income or loss
-192,399
-164,162
-130,650
138,377
-11,030
-
Income before tax
-162,606
-134,938
-119,499
138,590
-10,947
-
Income tax expense
1,052
1,018
-3,590
17,400
0
-
Income from continuing operations
-163,658
-135,956
-115,909
121,190
-10,947
-
Net income
-163,658
-135,956
-115,909
121,190
-10,947
-
Net income available to common shareholders
-163,658
-135,956
-115,909
121,190
-10,947
-
Basic EPS
-1.57
-
-1.39
1.46
-0.51
-0.30
Diluted EPS
-1.57
-
-1.39
1.37
-0.51
-0.30
Basic average shares
83,353
-
83,245
82,820
21,592
47,293
Diluted average shares
83,353
-
83,245
88,249
21,592
47,293